350 related articles for article (PubMed ID: 30282836)
1. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.
de Jong A; Jabbari A; Dai Z; Xing L; Lee D; Li MM; Duvic M; Hordinsky M; Norris DA; Price V; Mackay-Wiggan J; Clynes R; Christiano AM
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282836
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
Dai Z; Chen J; Chang Y; Christiano AM
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830087
[TBL] [Abstract][Full Text] [Related]
3. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
6. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory Vδ1
Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R
J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243
[TBL] [Abstract][Full Text] [Related]
8. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
[TBL] [Abstract][Full Text] [Related]
9. Toward the Clonotype Analysis of Alopecia Areata-Specific, Intralesional Human CD8+ T Lymphocytes.
Bertolini M; Uchida Y; Paus R
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):9-12. PubMed ID: 26551936
[TBL] [Abstract][Full Text] [Related]
10. Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model.
Hashimoto K; Yamada Y; Fujikawa M; Sekiguchi K; Uratsuji H; Mori S; Watanabe H; Matsumoto T
J Dermatol Sci; 2021 Oct; 104(1):21-29. PubMed ID: 34511266
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Petukhova L; Duvic M; Hordinsky M; Norris D; Price V; Shimomura Y; Kim H; Singh P; Lee A; Chen WV; Meyer KC; Paus R; Jahoda CA; Amos CI; Gregersen PK; Christiano AM
Nature; 2010 Jul; 466(7302):113-7. PubMed ID: 20596022
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.
Ito T; Ito N; Saatoff M; Hashizume H; Fukamizu H; Nickoloff BJ; Takigawa M; Paus R
J Invest Dermatol; 2008 May; 128(5):1196-206. PubMed ID: 18160967
[TBL] [Abstract][Full Text] [Related]
13. Alopecia areata: a review of disease pathogenesis.
Rajabi F; Drake LA; Senna MM; Rezaei N
Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
[TBL] [Abstract][Full Text] [Related]
14. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.
Jabbari A; Sansaricq F; Cerise J; Chen JC; Bitterman A; Ulerio G; Borbon J; Clynes R; Christiano AM; Mackay-Wiggan J
J Invest Dermatol; 2018 Jul; 138(7):1539-1545. PubMed ID: 29452121
[TBL] [Abstract][Full Text] [Related]
15. Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes.
Hashimoto K; Yamada Y; Sekiguchi K; Matsuda S; Mori S; Matsumoto T
J Dermatol Sci; 2021 Jun; 102(3):177-183. PubMed ID: 33994063
[TBL] [Abstract][Full Text] [Related]
16. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.
Bertolini M; Zilio F; Rossi A; Kleditzsch P; Emelianov VE; Gilhar A; Keren A; Meyer KC; Wang E; Funk W; McElwee K; Paus R
PLoS One; 2014; 9(5):e94260. PubMed ID: 24832234
[TBL] [Abstract][Full Text] [Related]
17. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives.
Paus R; Bertolini M
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S25-7. PubMed ID: 24326544
[TBL] [Abstract][Full Text] [Related]
18. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
[TBL] [Abstract][Full Text] [Related]
19. A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis.
Alli R; Nguyen P; Boyd K; Sundberg JP; Geiger TL
J Immunol; 2012 Jan; 188(1):477-86. PubMed ID: 22116824
[TBL] [Abstract][Full Text] [Related]
20. Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice.
Lee E; Kim M; Lee YJ
Front Immunol; 2022; 13():874778. PubMed ID: 35799786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]